These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8381342)

  • 1. Stavudine made available under parallel track policy.
    Clin Pharm; 1993 Jan; 12(1):7. PubMed ID: 8381342
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental AIDS drug d4T, now available to patients in critical need.
    Ann Allergy; 1993 Sep; 71(3):A24. PubMed ID: 8396862
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental AIDS drug, d4T, now available to patients in critical need.
    Ann Allergy; 1993 Apr; 70(4):A19. PubMed ID: 8385427
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
    AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Committee recommends approval of AIDS drug.
    Minn Med; 1994 Jul; 77(7):55. PubMed ID: 8052209
    [No Abstract]   [Full Text] [Related]  

  • 6. Stavudine.
    Lancet; 1992 Oct; 340(8825):967. PubMed ID: 1357358
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA triple header. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fast track toward new AIDS drugs.
    Long K; Long R
    Nurse Pract Forum; 1991 Jun; 2(2):80-1. PubMed ID: 1840952
    [No Abstract]   [Full Text] [Related]  

  • 9. Fast track for AIDS and cancer drugs.
    Gershon D
    Nature; 1990 Aug; 346(6286):685. PubMed ID: 2388690
    [No Abstract]   [Full Text] [Related]  

  • 10. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.
    Reichertz PS; Friend MS
    Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA looks at full approval for d4T. Food and Drug Administration.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: time to end the death trials.
    James JS
    AIDS Treat News; 1996 Aug; (no 252):1-4. PubMed ID: 11363751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA reiterates personal-use importation policy to buyers' clubs.
    Clin Pharm; 1993 Sep; 12(9):636-7. PubMed ID: 8306562
    [No Abstract]   [Full Text] [Related]  

  • 16. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
    Lovell MC
    Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies of 2',3'-didehydro-2',3'-dideoxythymidine (D4T) with other pyrimidine nucleoside analogues.
    Martin JC; Hitchcock MJ; Fridland A; Ghazzouli I; Kaul S; Dunkle LM; Sterzycki RZ; Mansuri MM
    Ann N Y Acad Sci; 1990; 616():22-8. PubMed ID: 1964029
    [No Abstract]   [Full Text] [Related]  

  • 18. [AIDS, intervention studies and pressure from patients].
    Danner SA
    Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1835-6. PubMed ID: 2215754
    [No Abstract]   [Full Text] [Related]  

  • 19. [AIDS studies with didanosine and stavudine].
    Dtsch Med Wochenschr; 1996 May; 121(22):A30. PubMed ID: 8646981
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA 'remains committed' to quick approval of AIDS drugs.
    Am Pharm; 1994 Dec; NS34(12):14. PubMed ID: 7856502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.